KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Cash (2017 - 2025)

Historic Change in Cash for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to -$34.4 million.

  • Twist Bioscience's Change in Cash fell 57888.82% to -$34.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$73.1 million, marking a year-over-year decrease of 6218.12%. This contributed to the annual value of -$43.7 million for FY2025, which is 2733.55% up from last year.
  • Latest data reveals that Twist Bioscience reported Change in Cash of -$34.4 million as of Q4 2025, which was down 57888.82% from -$18.5 million recorded in Q3 2025.
  • Twist Bioscience's Change in Cash's 5-year high stood at $216.0 million during Q1 2022, with a 5-year trough of -$274.2 million in Q4 2021.
  • Moreover, its 5-year median value for Change in Cash was -$10.3 million (2021), whereas its average is -$10.0 million.
  • Its Change in Cash has fluctuated over the past 5 years, first soared by 32739.02% in 2022, then plummeted by 139673.2% in 2024.
  • Over the past 5 years, Twist Bioscience's Change in Cash (Quarter) stood at -$274.2 million in 2021, then skyrocketed by 77.69% to -$61.2 million in 2022, then skyrocketed by 67.03% to -$20.2 million in 2023, then surged by 74.84% to -$5.1 million in 2024, then tumbled by 578.89% to -$34.4 million in 2025.
  • Its Change in Cash was -$34.4 million in Q4 2025, compared to -$18.5 million in Q3 2025 and -$9.0 million in Q2 2025.